Risk factor
Very vulnerable to price shocks
Profitability factor
Very strong margins and returns
About
Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E
Target Price
The average target price of COH.AX is 129 and suggests 6.33% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati